ReviewDiagnostics (Basel, Switzerland)2019

Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review.

Stergios Boussios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.